Study Summary
This trial aims to see if using a virtual care platform can reduce hospital visits and make virtual care safer for patients and providers.
- End Stage Renal Disease (ESRD)
- Kidney Failure
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
1 Primary · 10 Secondary · Reporting Duration: baseline, 3,6,9 and 12 months
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
2 Treatment Groups
Control Group
1 of 2
Intervention Group
1 of 2
Active Control
Experimental Treatment
340 Total Participants · 2 Treatment Groups
Primary Treatment: Intervention Group · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 0 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Are there any unfilled vacancies for this trial's participants?
"Affirmative, clinicaltrials.gov indicates that this trial is currently seeking subjects to enroll in the study. The listing was initially uploaded on June 30th 2022 and recently updated February 2nd 2023. 340 patients will be recruited from a single site for participation." - Anonymous Online Contributor
How many individuals can take part in the experiment?
"Affirmative. An examination of information on clinicaltrials.gov reveals that, as of June 30th 2022 and last updated February 2nd 2023, this trial is actively recruiting patients from one facility with a total number of 340 participants sought." - Anonymous Online Contributor